Abstract
Charcot-Marie-Tooth diseases (CMT) are a group of inherited peripheral nerve disorders clinically characterized by sensory loss, muscle weakness, and atrophy in distal limbs. CMTs are classified into demyelinating and axonal types based on reduced conduction velocities (CV) in the former (type-I) but normal in the latter (type-II). Recessive variants in IGHMBP2 have been reported to cause an axonal CMT (CMT2S). IGHMBP2 encodes Immunoglobulin helicase μ-binding protein 2, an enzyme involved in the protein translation process.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
